Union Bankshares Corp reduced its stake in shares of Johnson & Johnson (NYSE:JNJ) by 2.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 53,153 shares of the company’s stock after selling 1,213 shares during the quarter. Johnson & Johnson makes up 2.3% of Union Bankshares Corp’s holdings, making the stock its 6th largest position. Union Bankshares Corp’s holdings in Johnson & Johnson were worth $7,426,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently modified their holdings of JNJ. Harding Loevner LP acquired a new position in Johnson & Johnson during the 2nd quarter valued at about $106,000. Mitsubishi UFJ Securities Holdings Co. Ltd. increased its position in Johnson & Johnson by 29.9% during the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 870 shares of the company’s stock valued at $115,000 after buying an additional 200 shares in the last quarter. Mountain Capital Investment Advisors Inc acquired a new position in Johnson & Johnson during the 2nd quarter valued at about $124,000. Lenox Wealth Management Inc. increased its position in Johnson & Johnson by 1.7% during the 2nd quarter. Lenox Wealth Management Inc. now owns 1,457 shares of the company’s stock valued at $193,000 after buying an additional 24 shares in the last quarter. Finally, Intercontinental Wealth Advisors LLC acquired a new position in Johnson & Johnson during the 2nd quarter valued at about $200,000. Hedge funds and other institutional investors own 67.21% of the company’s stock.

How to Become a New Pot Stock Millionaire

JNJ has been the topic of several recent analyst reports. BTIG Research reaffirmed a “sell” rating and set a $110.00 target price on shares of Johnson & Johnson in a research report on Wednesday, January 24th. Vetr lowered Johnson & Johnson from a “buy” rating to a “hold” rating and set a $147.40 target price on the stock. in a research report on Monday, January 8th. Credit Suisse Group set a $154.00 price objective on Johnson & Johnson and gave the company a “hold” rating in a report on Monday, January 22nd. BMO Capital Markets increased their price objective on Johnson & Johnson to $161.00 and gave the company an “outperform” rating in a report on Tuesday, December 12th. Finally, Wells Fargo reissued an “outperform” rating and issued a $160.00 price objective (up from $155.00) on shares of Johnson & Johnson in a report on Friday, January 12th. Four research analysts have rated the stock with a sell rating, nine have issued a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $146.26.

In related news, VP Paulus Stoffels sold 155,342 shares of the firm’s stock in a transaction dated Thursday, February 15th. The stock was sold at an average price of $129.86, for a total transaction of $20,172,712.12. Following the sale, the vice president now directly owns 357,906 shares of the company’s stock, valued at $46,477,673.16. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.19% of the stock is owned by company insiders.

Shares of Johnson & Johnson stock opened at $131.19 on Thursday. The company has a market capitalization of $352,023.59, a PE ratio of 17.97, a P/E/G ratio of 2.09 and a beta of 0.77. Johnson & Johnson has a 1-year low of $120.95 and a 1-year high of $148.32. The company has a current ratio of 1.41, a quick ratio of 1.12 and a debt-to-equity ratio of 0.51.

Johnson & Johnson (NYSE:JNJ) last posted its earnings results on Tuesday, January 23rd. The company reported $1.74 EPS for the quarter, topping the consensus estimate of $1.72 by $0.02. The firm had revenue of $20.20 billion for the quarter, compared to analyst estimates of $20.08 billion. Johnson & Johnson had a return on equity of 29.00% and a net margin of 1.70%. Johnson & Johnson’s revenue for the quarter was up 11.5% compared to the same quarter last year. During the same period last year, the company earned $1.58 earnings per share. analysts predict that Johnson & Johnson will post 8.11 EPS for the current year.

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 13th. Investors of record on Tuesday, February 27th were issued a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a yield of 2.56%. The ex-dividend date was Monday, February 26th. Johnson & Johnson’s dividend payout ratio (DPR) is 861.54%.

COPYRIGHT VIOLATION NOTICE: This report was first published by Watch List News and is the property of of Watch List News. If you are accessing this report on another site, it was illegally copied and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be read at https://www.watchlistnews.com/johnson-johnson-jnj-position-decreased-by-union-bankshares-corp/1955980.html.

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.